Turn Therapeutics Inc.

TTRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$15.29

-$0.05 (-0.33%)

At close: Sep 22, 2026, 4:00 PM ET

$14.80

-$0.49 (-3.20%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $456.95M

Enterprise Value $452.78M

Beta 2.05

Average Volume 70.22K

Shares Outstanding (Diluted) 29.79M

Shares Change YoY 116.74%

Institutional Ownership 1.57%

Exchange NASDAQ

ISIN US90021W1053

Price Performance

Price Change 1M 63.4%

Price Change 3M 156.1%

Price Change 6M 349.9%

Price Change YTD 227.1%

Price Change 1Y 119.1%

Price Change 3Y 105.9%

Price Change 5Y 105.9%

1M CAGR (ann.) 47.4%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR 127.7%

Valuation

PE Ratio -52.90

Forward PE N/A

PEG Ratio 0.57

Forward PEG 8.42

PS Ratio N/A

Forward PS 90.50

PB Ratio 665.24

P/FCF Ratio -105.75

P/Adj. FCF Ratio -105.75

P/OCF Ratio -102.27

EV/Sales N/A

EV/EBIT -107.19

EV/EBITDA -108.65

EV/FCF -104.78

Earnings Yield -1.9%

FCF Yield -0.9%

Adj. FCF Yield -0.9%

Financial Health

Net Cash $4.18M

Total Debt $6.12M

Cash & Short-Term Investments $10.29M

Total Assets $16.96M

Current Ratio 1.19

Quick Ratio 1.19

Debt / Equity Ratio 8.91

Debt / EBITDA -1.47

Debt / FCF -1.42

OCF / Debt -0.71

Interest Coverage -28.93

Altman Z-Score 13.73

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -49.8%

Return on Equity -280.4%

Return on Invested Capital -84.7%

Return on Capital Employed -85.2%

Return on Tangible Assets -52.6%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 2

EPS Growth Next 3Y -93.1%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.09

EPS Growth Est (next Q) 28.6%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $9

Price Target Upside -41.3%

Cash Flow

Operating Cash Flow $-4.32M

Free Cash Flow $-4.32M

Adj. Free Cash Flow $-4.32M

FCF Per Share -$0.15

OCF Per Share -$0.15

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-56.82K

Operating Income $-6.98M

EBITDA $-4.17M

Net Income $-8.45M

EPS (Diluted) -$0.29

Revenue / Employee N/A

Profit / Employee $-4.22M

Employees 2